Comment on FDA Issues Plan To Avoid Heparin Contamination

FDA Issues Plan To Avoid Heparin Contamination

(Adds details, background) By Lewis Krauskopf Feb 10 (Reuters) - U.S. health regulators issued recommendations to manufacturers to ensure the safe production of the blood-clot prevention drug heparin, four years after a contamination involving the widely used product set off concerns about the global pharmaceutical supply chain. The draft guidance, posted on the website of the Food and Drug Administration, is designed to help manufacturers of active ingredients, finished products and others better control heparin to avoid contamination.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News